Womens HealthInfo Center
New HER2+ Breast Cancer Treatment Recommendation
More than a quarter of women diagnosed with breast cancer have high levels of HER2, a protein that makes the cancer grow faster and more likely to return. New research has discovered one treatment method that’s been used may no longer be necessary.
Breast Cancer Rx Linked to Heart Failure
Roughly one in four breast cancers has too much of a protein called HER2, which makes the cancer grow faster. The medication Herceptin (trastuzumab) targets the HER2 protein to help breast cancer patients live longer. But this medication may be linked to heart problems.
New Option for Advanced HER2 Breast Cancer
HER2 is a protein that can be overexpressed in breast cancer, causing an aggressive disease. While there are treatments that target HER2, this form of cancer is tenacious. Scientists have found a new treatment option for this type of breast cancer.
Living Longer with HER2+ Breast Cancer
HER2-positive breast cancers are more aggressive forms of breast cancer. These tumors contain a protein that promotes cancer cell growth. HER2-positive breast cancers can also be driven by the hormone estrogen.
Skipping Chemo to Treat a Breast Cancer
Aggressive breast cancer requires aggressive treatment. The therapy for one menacing type of breast cancer – HER2-positive – almost always involves chemotherapy. Maybe not for everyone, though.
Cancer Rx May Prevent Spread of Breast Cancer
Herceptin (trastuzumab) is a leading medication used to treat a particularly aggressive form of breast cancer, known as HER2-positive. Researchers are now suggesting the medicine may be useful in treating other forms of breast cancer.
New HER2+ Breast Cancer Rx Approved
Patients with HER2-positive breast cancer have a new medication to treat the disease in its late stages, after it has started to spread.
Can Resistance to HER2 Therapy Be Overcome?
The standard of care for HER2-positive breast cancer is Herceptin ( trastuzumab ). Over time, though, this aggressive cancer can become resistant to the medication. New research may have discovered a way around this resistance.
One Equals More Than Two
Herceptin is the standard medication for treating HER2-positive breast cancer. There has been some question about how long this treatment should last. A new study has answered that question.
Heart Breaking Complications
Scientists have known for a while that some chemotherapy agents can cause heart disease in some patients. This complication is now being seen in some women taking a popular breast cancer drug.